Topical metal chelation therapy ameliorates oxidation-induced toxicity in diabetic cataract

Min Zhang, Mohammad Shoeb, Ping Liu, Tianlin Xiao, Dale Hogan, Ira G. Wong, Gerald Campbell, Naseem Ansari

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Oxidative stress plays a critical role in cataractogenesis, the leading cause of blindness worldwide. Since transition metals generate reactive oxygen species (ROS) formation, metal chelation therapy has been proposed for treatment of cataracts. However, the effectiveness of most chelators is limited by low tissue penetrability. This study is the first to demonstrate that the topically applied divalent metal chelator ethylenediamine tetraacetic acid (EDTA) combined with the carrier and permeability enhancer methyl sulfonyl methane (MSM) ameliorates both oxidation-induced lens opacification and the associated toxic accumulation of protein-4-hydroxynonenal (HNE) adducts. Both in vitro (rat lens culture) and in vivo (diabetic rats), EDTA-MSM (1) significantly reduced lens opacification by about 40-50%, (2) significantly diminished lens epithelial cell proliferation and fiber cell swelling in early stages of cataract formation in vivo, and (3) notably decreased the levels of protein-HNE adducts. These findings have important implications specifically for the treatment of cataract and generally for other diseases in which oxidative stress plays a key pathogenic role.

Original languageEnglish (US)
Pages (from-to)380-391
Number of pages12
JournalJournal of Toxicology and Environmental Health - Part A: Current Issues
Volume74
Issue number6
DOIs
StatePublished - Jan 2011

Fingerprint

Chelation Therapy
ethylenediamine
Chelation
Cataract
Lenses
Toxicity
Metals
Oxidation
Oxidative stress
Methane
Chelating Agents
Rats
Oxidative Stress
Acids
Poisons
Cell proliferation
Blindness
Transition metals
Swelling
Permeability

ASJC Scopus subject areas

  • Health, Toxicology and Mutagenesis
  • Toxicology

Cite this

Topical metal chelation therapy ameliorates oxidation-induced toxicity in diabetic cataract. / Zhang, Min; Shoeb, Mohammad; Liu, Ping; Xiao, Tianlin; Hogan, Dale; Wong, Ira G.; Campbell, Gerald; Ansari, Naseem.

In: Journal of Toxicology and Environmental Health - Part A: Current Issues, Vol. 74, No. 6, 01.2011, p. 380-391.

Research output: Contribution to journalArticle

Zhang, Min ; Shoeb, Mohammad ; Liu, Ping ; Xiao, Tianlin ; Hogan, Dale ; Wong, Ira G. ; Campbell, Gerald ; Ansari, Naseem. / Topical metal chelation therapy ameliorates oxidation-induced toxicity in diabetic cataract. In: Journal of Toxicology and Environmental Health - Part A: Current Issues. 2011 ; Vol. 74, No. 6. pp. 380-391.
@article{8c0c59edb47e415f80dd6d6dab01bfed,
title = "Topical metal chelation therapy ameliorates oxidation-induced toxicity in diabetic cataract",
abstract = "Oxidative stress plays a critical role in cataractogenesis, the leading cause of blindness worldwide. Since transition metals generate reactive oxygen species (ROS) formation, metal chelation therapy has been proposed for treatment of cataracts. However, the effectiveness of most chelators is limited by low tissue penetrability. This study is the first to demonstrate that the topically applied divalent metal chelator ethylenediamine tetraacetic acid (EDTA) combined with the carrier and permeability enhancer methyl sulfonyl methane (MSM) ameliorates both oxidation-induced lens opacification and the associated toxic accumulation of protein-4-hydroxynonenal (HNE) adducts. Both in vitro (rat lens culture) and in vivo (diabetic rats), EDTA-MSM (1) significantly reduced lens opacification by about 40-50{\%}, (2) significantly diminished lens epithelial cell proliferation and fiber cell swelling in early stages of cataract formation in vivo, and (3) notably decreased the levels of protein-HNE adducts. These findings have important implications specifically for the treatment of cataract and generally for other diseases in which oxidative stress plays a key pathogenic role.",
author = "Min Zhang and Mohammad Shoeb and Ping Liu and Tianlin Xiao and Dale Hogan and Wong, {Ira G.} and Gerald Campbell and Naseem Ansari",
year = "2011",
month = "1",
doi = "10.1080/15287394.2011.538835",
language = "English (US)",
volume = "74",
pages = "380--391",
journal = "Journal of Toxicology and Environmental Health - Part A: Current Issues",
issn = "1528-7394",
publisher = "Taylor and Francis Ltd.",
number = "6",

}

TY - JOUR

T1 - Topical metal chelation therapy ameliorates oxidation-induced toxicity in diabetic cataract

AU - Zhang, Min

AU - Shoeb, Mohammad

AU - Liu, Ping

AU - Xiao, Tianlin

AU - Hogan, Dale

AU - Wong, Ira G.

AU - Campbell, Gerald

AU - Ansari, Naseem

PY - 2011/1

Y1 - 2011/1

N2 - Oxidative stress plays a critical role in cataractogenesis, the leading cause of blindness worldwide. Since transition metals generate reactive oxygen species (ROS) formation, metal chelation therapy has been proposed for treatment of cataracts. However, the effectiveness of most chelators is limited by low tissue penetrability. This study is the first to demonstrate that the topically applied divalent metal chelator ethylenediamine tetraacetic acid (EDTA) combined with the carrier and permeability enhancer methyl sulfonyl methane (MSM) ameliorates both oxidation-induced lens opacification and the associated toxic accumulation of protein-4-hydroxynonenal (HNE) adducts. Both in vitro (rat lens culture) and in vivo (diabetic rats), EDTA-MSM (1) significantly reduced lens opacification by about 40-50%, (2) significantly diminished lens epithelial cell proliferation and fiber cell swelling in early stages of cataract formation in vivo, and (3) notably decreased the levels of protein-HNE adducts. These findings have important implications specifically for the treatment of cataract and generally for other diseases in which oxidative stress plays a key pathogenic role.

AB - Oxidative stress plays a critical role in cataractogenesis, the leading cause of blindness worldwide. Since transition metals generate reactive oxygen species (ROS) formation, metal chelation therapy has been proposed for treatment of cataracts. However, the effectiveness of most chelators is limited by low tissue penetrability. This study is the first to demonstrate that the topically applied divalent metal chelator ethylenediamine tetraacetic acid (EDTA) combined with the carrier and permeability enhancer methyl sulfonyl methane (MSM) ameliorates both oxidation-induced lens opacification and the associated toxic accumulation of protein-4-hydroxynonenal (HNE) adducts. Both in vitro (rat lens culture) and in vivo (diabetic rats), EDTA-MSM (1) significantly reduced lens opacification by about 40-50%, (2) significantly diminished lens epithelial cell proliferation and fiber cell swelling in early stages of cataract formation in vivo, and (3) notably decreased the levels of protein-HNE adducts. These findings have important implications specifically for the treatment of cataract and generally for other diseases in which oxidative stress plays a key pathogenic role.

UR - http://www.scopus.com/inward/record.url?scp=79251621782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79251621782&partnerID=8YFLogxK

U2 - 10.1080/15287394.2011.538835

DO - 10.1080/15287394.2011.538835

M3 - Article

VL - 74

SP - 380

EP - 391

JO - Journal of Toxicology and Environmental Health - Part A: Current Issues

JF - Journal of Toxicology and Environmental Health - Part A: Current Issues

SN - 1528-7394

IS - 6

ER -